Grafa News and Videos — Page 690

Arcus Biosciences (NYSE:RCUS) has announced a new clinical trial collaboration and supply agreement with Bristol Myers Squibb (NYSE:BMY) aimed at advancing treatment options for advanced renal cell carcinoma (RCC).

Treasure Global (NASDAQ:TGL) has unveiled its preliminary outlook for fiscal year 2026, forecasting revenue growth in excess of 100% on a year-over-year basis.

Avalyn Pharma (NASDAQ:AVLN) provided a comprehensive update on its financial position and clinical development programs for the first quarter of 2026, underscored by a strengthened capital base following its recent initial public offering.

Rent the Runway (NASDAQ:RENT) delivered a strong start to the fiscal year, reporting first-quarter revenue that outpaced corporate guidance even as the company moves through a high-level executive transition.

Accel Entertainment (NYSE:ACEL) announced that its subsidiary, Toucan Gaming, has acquired the assets of Rice Palace and South Louisiana Gaming, the owner and operator of the Rice Palace Truck Stop Casino.

TG Therapeutics (NASDAQ:TGTX) announced positive data from a Phase 1 clinical trial evaluating a high-concentration subcutaneous formulation of its multiple sclerosis therapy Briumvi (ublituximab-xiiy).

Wellington Management has signed a definitive agreement to acquire Hartford Funds from insurer The Hartford Financial Services Group (NYSE:HIG), a transaction that structurally consolidates a 40-year sub-advisory alliance into a unified asset management platform.

Axsome Therapeutics (NASDAQ:AXSM) has resolved all outstanding U.S. patent litigation concerning its sleep disorder medication, Sunosi, securing the drug's proprietary market positioning for nearly another two decades.

Sprinklr (NYSE:CXM) reported top-line expansion and a successful shift into GAAP operational profitability for its fiscal first quarter ended April 30, 2026, capitalising on continuous adoption of its unified customer experience management platform.

Destination XL Group (NASDAQ:DXLG) reported a 2.1% decline in sales for the first quarter of fiscal 2026 as the specialty retailer navigates a challenging consumer environment, while doubling down on digital and fit-technology initiatives.